top of page

HRTX

Heron Therapeutics

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$111.9M

Burn Rate (Qtr)

$43.9M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

HRTX

BPIQ_Logo_RGB-01.jpg

Company Profile

For AMP's current thesis as well as the bull and bear thesis on HRTX go here: https://bit.ly/3dT4xyo

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.

Recent Posts

See what the community is saying - click to see full post.

VNDA - Interim Analysis from #ODYSSEY Study Shows Tradipitant may Accelerate Clinical Improvement in Patients with COVID_19 Pneumonia

HRTX - HTX-011 Post Operative Pain PDUFA (3/26/2020)

HRTX

bottom of page